North Star Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-7,400
| Closed | -$239K | – | 248 |
|
|
2016
Q4 | $239K | Hold |
7,400
| – | – | 0.03% | 215 |
|
|
2016
Q3 | $253K | Hold |
7,400
| – | – | 0.03% | 208 |
|
|
2016
Q2 | $250K | Hold |
7,400
| – | – | 0.03% | 210 |
|
|
2016
Q1 | $392K | Hold |
7,400
| – | – | 0.05% | 183 |
|
|
2015
Q4 | $568K | Hold |
7,400
| – | – | 0.07% | 168 |
|
|
2015
Q3 | $304K | Hold |
7,400
| – | – | 0.04% | 198 |
|
|
2015
Q2 | $523K | Buy |
7,400
+2,300
| +45% | +$163K | 0.06% | 179 |
|
|
2015
Q1 | $453K | Sell |
5,100
-2,200
| -30% | -$195K | 0.05% | 187 |
|
|
2014
Q4 | $647K | Hold |
7,300
| – | – | 0.07% | 166 |
|
|
2014
Q3 | $708K | Buy |
7,300
+2,300
| +46% | +$223K | 0.08% | 160 |
|
|
2014
Q2 | $459K | Hold |
5,000
| – | – | 0.05% | 186 |
|
|
2014
Q1 | $350K | Buy |
+5,000
| New | +$350K | 0.04% | 194 |
|